Skip to main content

Harmonization of Drug Approval Guidelines in Alzheimer’s and Parkinson’s Diseases

  • Chapter
Progress in Alzheimer’s and Parkinson’s Diseases

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 49))

  • 24 Accesses

Abstract

The world’s population is aging at an accelerated rate. In the United States, Western Europe and Japan where individuals over the age of 60 represent more than 20% of the population, the most rapidly growing population segment is people age 85 and over. Countries in South America and Asia, such as China and India, are aging at an even more rapid rate. Current projections suggest that more older people will be living in the developing world than in the developed world. It is therefore expected that most countries of the world will experience a rapid rise in diseases of aging, such as Alzheimer’s disease and Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • D’Arcy, P.F., Harron, D.W.G., eds., 1991, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Proc. First Int. Conf. Harmonisation, Orlando, Florida.

    Google Scholar 

  • D’Arcy, P.F., Harron, D.W.G., eds., 1993, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Proc. Second Int. Conf. Harmonisation, Orlando, Florida.

    Google Scholar 

  • Kieburtz, K., Rinne, U.K., et al., 1996, The COMT Inhibitor Entacapone Increases “On” Time in Levodopa-Treated PD Patients with Motor Fluctuations; Report of Two Randomized, Placebo-Controlled Trials. Mov. Dis. Abstract,. 11(5): 595–596).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Doody, R.S., Davidson, M., Shoulson, I., Whitehouse, P. (1998). Harmonization of Drug Approval Guidelines in Alzheimer’s and Parkinson’s Diseases. In: Fisher, A., Hanin, I., Yoshida, M. (eds) Progress in Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 49. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5337-3_124

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5337-3_124

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7435-0

  • Online ISBN: 978-1-4615-5337-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics